1. Research Objectives and Assumptions

   • Research Objectives
   • Assumptions
   • Abbreviations

2. Market Purview

   • Report Description
     • Market Definition and Scope
   • Executive Summary
     • Market Snapshot, By Drug Class
     • Market Snapshot, By Distribution Channel
     • Market Snapshot, By Region
   • Coherent Opportunity Map (COM)

3. Market Dynamics, Regulations, and Trends Analysis

   • Drivers
   • Restraints
   • Opportunities
   • Impact Analysis
   • Pipeline Analysis
   • Regulatory Scenario
   • Recent Product Approval/Launch
   • PEST Analysis
   • Epidemiology

4. Global Eosinophilic Esophagitis Market, By Drug Class, 2021 – 2033, (US$ Mn)

   •  Introduction
     • Market Share Analysis, 2026 and 2033 (%)
     • Y-o-Y Growth Analysis, 2022 – 2033
     • Segment Trends
   • Corticosteroids
     • Introduction
     • Market Size and Forecast, and Y-o-Y Growth, 2021 – 2033, (US$ Mn)
       • Budesonide
         • Introduction
         • Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (US$ Million)
           • Jorveza
             1. Introduction
             2. Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (US$ Million)
           • Off-label budesonide
             1. Introduction
             2. Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (US$ Million)
       • Fluticasone
         • Introduction
         • Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (US$ Million)
   • Proton Pump Inhibitor (PPI)
     • Introduction
     • Market Size and Forecast, and Y-o-Y Growth, 2021 – 2033, (US$ Mn)
       • Omeprazole
         • Introduction
         • Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (US$ Million)
       • Esomeprazole
         • Introduction
         • Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (US$ Million)
       • Others
         • Introduction
         • Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (US$ Million)
   • Late Stage Pipeline Drugs
     • Introduction
     • Market Size and Forecast, and Y-o-Y Growth, 2021 – 2033, (US$ Mn)
       • Dupixent
         • Introduction
         • Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (US$ Million)
       • APT-1012
         • Introduction
         • Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (US$ Million)
       • Lirentelimab (AK002)
         • Introduction
         • Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (US$ Million)
       • Cendakimab
         • Introduction
         • Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (US$ Million)
       • Etrasimod
         • Introduction
         • Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (US$ Million)
       • TAK-721
         • Introduction
         • Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (US$ Million)
       • Omilancor (BT-11)
         • Introduction
         • Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (US$ Million)

5. Global Eosinophilic Esophagitis Market, By Distribution Channel, 2021 – 2033, (US$ Mn)

   • Introduction
     • Market Share Analysis, 2026 and 2033 (%)
     • Y-o-Y Growth Analysis, 2022 – 2033
     • Segment Trends
   • Hospital Pharmacies
     • Introduction
     • Market Size and Forecast, and Y-o-Y Growth, 2021 – 2033, (US$ Mn)
   • Retail Pharmacies
     • Introduction
     • Market Size and Forecast, and Y-o-Y Growth, 2021 – 2033, (US$ Mn)
   • Online Pharmacies
     • Introduction
     • Market Size and Forecast, and Y-o-Y Growth, 2021 – 2033, (US$ Mn)

6. Global Eosinophilic Esophagitis Market, By Region, 2021 – 2033, (US$ Mn)

   • Introduction
     • Market Share Analysis, By Region, 2022 and 2029 (%)
     • Y-o-Y Growth Analysis, For Regions, 2022–2033
     • Regional Trends
   • North America
     • Introduction
     • Market Size and Forecast, and Y-o-Y Growth, By Drug Class, 2021 – 2033, (US$ Mn)
     • Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2021 – 2033, (US$ Mn)
     • Market Size and Forecast, and Y-o-Y Growth, By Country, 2021 – 2033, (US$ Mn)
       • U.S.
       • Canada
   • Latin America
     • Introduction
     • Market Size and Forecast, and Y-o-Y Growth, By Drug Class, 2021 – 2033, (US$ Mn)
     • Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2021 – 2033, (US$ Mn)
     • Market Size and Forecast, and Y-o-Y Growth, By Country, 2021 – 2033, (US$ Mn)
       • Brazil
       • Mexico
       • Argentina
       • Rest of Latin America
   • Europe
     • Introduction
     • Market Size and Forecast, and Y-o-Y Growth, By Drug Class, 2021 – 2033, (US$ Mn)
     • Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2021 – 2033, (US$ Mn)
     • Market Size and Forecast, and Y-o-Y Growth, By Country, 2021 – 2033, (US$ Mn)
       • U.K.
       • Germany
       • France
       • Italy
       • Spain
       • Russia
       • Rest of Europe
   • Asia Pacific
     • Introduction
     • Market Size and Forecast, and Y-o-Y Growth, By Drug Class, 2021 – 2033, (US$ Mn)
     • Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2021 – 2033, (US$ Mn)
     • Market Size and Forecast, and Y-o-Y Growth, By Country, 2021 – 2033, (US$ Mn)
       • China
       • India
       • Japan
       • Australia
       • South Korea
       • ASEAN
       • Rest of Asia Pacific
   • Middle East
     • Introduction
     • Market Size and Forecast, and Y-o-Y Growth, By Drug Class, 2021 – 2033, (US$ Mn)
     • Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2021 – 2033, (US$ Mn)
     • Market Size and Forecast, and Y-o-Y Growth, By Country, 2021 – 2033, (US$ Mn)
       • GCC
       • Israel
       • Rest of Middle East
   • Africa
     • Introduction
     • Market Size and Forecast, and Y-o-Y Growth, By Drug Class, 2021 – 2033, (US$ Mn)
     • Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2021 – 2033, (US$ Mn)
     • Market Size and Forecast, and Y-o-Y Growth, By Country/Region, 2021 – 2033, (US$ Mn)
       • North Africa
       • Central Africa
       • South Africa

7. Competitive Landscape

   • Heat Map Analysis
   • Market Share Analysis
     • Ellodi Pharmaceuticals.
       • Company Highlights
       • Product Portfolio
       • Key Highlights
       • Strategies
     • EsoCap AG
       • Company Highlights
       • Product Portfolio
       • Key Highlights
       • Strategies
     • GlaxoSmithKline plc.
       • Company Highlights
       • Product Portfolio
       • Key Highlights
       • Financial Performance
       • Strategies
     • Teva Pharmaceutical Industries Ltd
       • Company Highlights
       • Product Portfolio
       • Key Highlights
       • Financial Performance
       • Strategies
     • Cipla Limited
       • Company Highlights
       • Product Portfolio
       • Key Highlights
       • Financial Performance
       • Strategies
     • Sun Pharmaceutical Industries Limited
       • Company Highlights
       • Product Portfolio
       • Key Highlights
       • Financial Performance
       • Strategies
     • AstraZeneca Plc
       • Company Highlights
       • Product Portfolio
       • Key Highlights
       • Financial Performance
       • Strategies
     • Sanofi S.A.
       • Company Highlights
       • Product Portfolio
       • Key Highlights
       • Financial Performance
       • Strategies
     • Arena Pharmaceuticals, Inc.
       • Company Highlights
       • Product Portfolio
       • Key Highlights
       • Strategies
     • Takeda Pharmaceutical Company Limited
       • Company Highlights
       • Product Portfolio
       • Key Highlights
       • Strategies
     • Revolo Biotherapeutics
       • Company Highlights
       • Product Portfolio
       • Key Highlights
       • Strategies
     • Allakos Inc.
       • Company Highlights
       • Product Portfolio
       • Key Highlights
       • Strategies
     • Bristol-Myers Squibb Co
       • Company Highlights
       • Product Portfolio
       • Key Highlights
       • Strategies
     • Calypso Biotech
       • Company Highlights
       • Product Portfolio
       • Key Highlights
       • Strategies
     • DBV Technologies
       • Company Highlights
       • Product Portfolio
       • Key Highlights
       • Strategies
     • Landos Biopharma, Inc.
       • Company Highlights
       • Product Portfolio
       • Key Highlights
       • Strategies
     • Glenmark Pharmaceuticals
       • Company Highlights
       • Product Portfolio
       • Key Highlights
       • Financial Performance
       • Strategies
     • Alkem Laboratories Ltd.
       • Company Highlights
       • Product Portfolio
       • Key Highlights
       • Financial Performance
       • Strategies
     • Quorum Innovations LLC
       • Company Highlights
       • Product Portfolio
       • Key Highlights
       • Strategies
     • Falk Pharma GmbH
       • Company Highlights
       • Product Portfolio
       • Key Highlights
       • Strategies

8.  Analyst Recommendation

   • Wheel of Fortune
   • Analyst View
   • Coherent Opportunity Map

9. Section

   • References
   • Research Methodology
   • About Us and Sales Contact